| Yoav H Messinger, MD | |
|
347 North Smith Avenue, St Paul, MN 55102 | |
| (651) 220-6732 | |
| (651) 220-6005 |
| Full Name | Yoav H Messinger |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Hematology-oncology |
| Location | 347 North Smith Avenue, St Paul, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063482388 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0207X | Pediatrics - Pediatric Hematology-oncology | 36366 (Minnesota) | Primary |
| Entity Name | Children's Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932208808 PECOS PAC ID: 2668370966 Enrollment ID: O20040406000939 |
News Archive
HHS Secretary Sebelius, Jay Angoff, director of the Office of Consumer Information and Insurance Oversight, and Keysha Brooks Coley, the director of Federal Relations with the American Cancer Society, will host a web chat Friday, April 30 to discuss important insurance reforms in the new legislation and recent developments that have led to the ending of controversial practices like rescissions.
Tuesday's budget saw the Australian government allocate $7.4 billion for health. Many critics have brought to notice that only $200 million has gone towards mental health. The Rudd government has denied such accusations.
Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine.
AcademyHealth and the Robert Wood Johnson Foundation have awarded 10 scholarships to graduate students who demonstrate outstanding potential to contribute to the field of public health systems research.
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
› Verified 5 days ago
| Entity Name | Gillette Childrens Specialty Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225119175 PECOS PAC ID: 0547169211 Enrollment ID: O20040503000485 |
News Archive
HHS Secretary Sebelius, Jay Angoff, director of the Office of Consumer Information and Insurance Oversight, and Keysha Brooks Coley, the director of Federal Relations with the American Cancer Society, will host a web chat Friday, April 30 to discuss important insurance reforms in the new legislation and recent developments that have led to the ending of controversial practices like rescissions.
Tuesday's budget saw the Australian government allocate $7.4 billion for health. Many critics have brought to notice that only $200 million has gone towards mental health. The Rudd government has denied such accusations.
Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine.
AcademyHealth and the Robert Wood Johnson Foundation have awarded 10 scholarships to graduate students who demonstrate outstanding potential to contribute to the field of public health systems research.
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yoav H Messinger, MD 2910 Centre Pointe Drive, 35 121a, Roseville, MN 55113 Ph: (651) 855-2327 | Yoav H Messinger, MD 347 North Smith Avenue, St Paul, MN 55102 Ph: (651) 220-6732 |
News Archive
HHS Secretary Sebelius, Jay Angoff, director of the Office of Consumer Information and Insurance Oversight, and Keysha Brooks Coley, the director of Federal Relations with the American Cancer Society, will host a web chat Friday, April 30 to discuss important insurance reforms in the new legislation and recent developments that have led to the ending of controversial practices like rescissions.
Tuesday's budget saw the Australian government allocate $7.4 billion for health. Many critics have brought to notice that only $200 million has gone towards mental health. The Rudd government has denied such accusations.
Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine.
AcademyHealth and the Robert Wood Johnson Foundation have awarded 10 scholarships to graduate students who demonstrate outstanding potential to contribute to the field of public health systems research.
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
› Verified 5 days ago
Kimberly K Rathmann, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 451 North Dunlap Street, Mail Stop 32700a, St Paul, MN 55104 Phone: 651-999-4700 Fax: 651-999-4781 | |
Krishna M Saxena, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Children's Specialty Clinic-diabetes/endocrinology-stpl, 347 North Smith Avenue, St Paul, MN 55102 Phone: 651-220-6818 Fax: 651-220-6064 | |
Dr. Carolyn J Levitt, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 347 North Smith Avenue, 401, Midwest Childrens Resource Center, St Paul, MN 55102 Phone: 651-220-6750 Fax: 651-220-6770 | |
Sylvia M Sekhon, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2500 Como Avenue, Mail Stop 31100a, St Paul, MN 55108 Phone: 651-641-6200 Fax: 651-641-6205 | |
Susan C Goodale, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 393 N Dunlap St, Suite 300, St Paul, MN 55104 Phone: 651-645-4693 Fax: 651-645-6503 | |
Richard D Andersen, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 347 N Smith Ave, Childrens Specialty Clinic Infectious Diseases Stpl, St Paul, MN 55102 Phone: 651-220-6444 Fax: 651-220-7233 |